Hemant Surgical Industries P/B Ratio
Current P/B Ratio
3.42
High Valuation
High - Premium to book value, growth expectations or asset-light model
Hemant Surgical Industries (HSIL) P/B ratio is 3.42 (High), book value per share ₹63.00 vs Healthcare average P/B of -1.0 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see Hemant Surgical Industries share price chart.
Current Valuation Metrics
P/B Ratio
3.42
Current Price
₹
Book Value/Share
₹63.00
Exchange
None
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹63 Cr
Share Capital
₹10 Cr
Reserves & Surplus
₹53 Cr
Outstanding Shares
10,000,000
Book Value per Share
₹63.00
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
-1.0
Sector Median
0.62
Sector Rank
#11 of 50
Sector Percentile
22.0%
HSIL P/B Ratio — Valuation Insights & Book Value Analysis
Hemant Surgical Industries price-to-book ratio interpretation, valuation status and historical context — current P/B 3.42 (High). Compare with HSIL fair value to assess whether the stock is under or overvalued.
- Stock appears overvalued with PB of 3.42, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -1.0
HSIL vs Healthcare Peers — P/B Ratio Comparison
Hemant Surgical Industries P/B 3.42 vs Healthcare average -1.0, median 0.62 — range -36.63–1.05.
Sector Average
-1.0
Sector Median
0.62
Lowest P/B
-36.63
Highest P/B
1.05
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -36.63 | ₹28 | Low |
| Sun Pharma Advanced Rese… | SPARC | -13.83 | ₹4,744 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.35 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.09 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |